Takafumi Hashimoto
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 3
-
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 2
-
- Peroxisome Proliferator-Activated Receptors 3
- PI3K/AKT/mTOR signaling in cancer 2
-
- Dialysis and Renal Disease Management 2
-
- Erythropoietin and Anemia Treatment 2
- Co-authors
- Michiyo MiyawakiKenji SugioMiyuki AbeTatsuro OkamotoHideya TakeuchiAtsushi OsoegawaRyōji KobayashiKiyomi Sakata
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Takafumi Hashimoto
30 papers receiving 411 citations
Peers
Comparison fields: 5 of 79
- Clinical Biochemistry 71
- Oncology 137
- Internal Medicine 17
- Reproductive Medicine 37
- Cancer Research 50
Countries citing papers authored by Takafumi Hashimoto
This map shows the geographic impact of Takafumi Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takafumi Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takafumi Hashimoto more than expected).
Fields of papers citing papers by Takafumi Hashimoto
This network shows the impact of papers produced by Takafumi Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takafumi Hashimoto. The network helps show where Takafumi Hashimoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takafumi Hashimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2019 | 10 | |
| 8 | 2019 | 41 | |
| 9 | 2019 | 10 | |
| 10 | 2018 | 15 | |
| 11 | 2018 | 4 | |
| 12 | 2017 | 53 | |
| 13 | 2015 | 1 | |
| 14 | 2014 | 2 | |
| 15 | 2014 | 0 | |
| 16 | 2012 | 5 | |
| 17 | 2010 | 39 | |
| 18 | 1999 | 19 | |
| 19 | 1995 | 17 | |
| 20 | Color Doppler echography of breast diseases: Detection rate of color flow signals and significance of color Doppler echography in breast diseases | 1992 | 1 |
About Takafumi Hashimoto
Takafumi Hashimoto is a scholar working on Pulmonary and Respiratory Medicine, Clinical Biochemistry and Oncology, having authored 35 papers that have together received 421 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (4 papers), Metabolism and Genetic Disorders (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Dialysis and Renal Disease Management (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Erythropoietin and Anemia Treatment (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Clinical Biochemistry (71 citations), Oncology (137 citations) and Internal Medicine (17 citations). Takafumi Hashimoto has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Michiyo Miyawaki, Kenji Sugio, Miyuki Abe, Tatsuro Okamoto, Hideya Takeuchi, Atsushi Osoegawa, Ryōji Kobayashi, Kiyomi Sakata, Akira Okayama and Junko Tamaki. Their work appears in journals such as Science, PLoS ONE and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.